Serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of diagnosis

被引：0
|
作者：
Didem S. Dede
Cagatay Arslan
Kadri Altundag
机构：
[1] Hacettepe University Institute of Oncology,Department of Medical Oncology
来源：
Medical Oncology | 2010年 / 27卷
关键词：
Breast Cancer; Epidermal Growth Factor Receptor; Breast Cancer Patient; Progesterone Receptor; Recurrent Breast Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1429 / 1429
相关论文
共 50 条
  • [1] Serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of diagnosis
    Dede, Didem S.
    Arslan, Cagatay
    Altundag, Kadri
    MEDICAL ONCOLOGY, 2010, 27 (04) : 1429 - 1429
  • [2] Comparison of serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of metastases and serum levels at the time of first diagnosis
    Dede, D. Sener
    Aksoy, S.
    Bulut, N.
    Dizdar, O.
    Arik, Z.
    Gullu, I.
    Ozisik, Y.
    Altundag, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Serum CEA and CA 15-3 levels according to breast cancer subtypes
    Dede, Isa
    Utkan, Gungor
    Akbulut, Hakan
    Urun, Yuksel
    Mizrak, Dilsa
    Icli, Fikri
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes
    Park, B. -W.
    Oh, J. -W.
    Kim, J. -H.
    Park, S. H.
    Kim, K. -S.
    Kim, J. H.
    Lee, K. S.
    ANNALS OF ONCOLOGY, 2008, 19 (04) : 675 - 681
  • [5] Serum levels of CEA and CA 15-3 in different subtypes of recurrent breast cancer
    Mizrak, D.
    Ozturk, B.
    Kubilay, P.
    Akbulut, H.
    Onur, H.
    BREAST, 2015, 24 : S83 - S83
  • [6] Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
    F G Ebeling
    P Stieber
    M Untch
    D Nagel
    G E Konecny
    U M Schmitt
    A Fateh-Moghadam
    D Seidel
    British Journal of Cancer, 2002, 86 : 1217 - 1222
  • [7] Serum CEA and CA 15-3 as prognostic factors in primary breast cancer
    Ebeling, FG
    Stieber, P
    Untch, M
    Nagel, D
    Konecny, GE
    Schmitt, UM
    Fateh-Moghadam, A
    Seidel, D
    BRITISH JOURNAL OF CANCER, 2002, 86 (08) : 1217 - 1222
  • [8] Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer
    Eskelinen, M
    Kataja, V
    Hamalainen, E
    Kosma, VM
    Penttila, I
    Alhava, E
    ANTICANCER RESEARCH, 1997, 17 (2B) : 1231 - 1234
  • [9] Correlation of CA125, CA153, and CEA levels in the diagnosis and prognosis of triple-negative breast cancer
    Lou, Weijun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (05): : 3219 - 3225
  • [10] CA 15-3 IN BREAST-CANCER - COMPARISON WITH CEA
    MAIGRE, M
    FUMOLEAU, P
    RICOLLEAU, G
    GUILLARD, Y
    CUSSAC, A
    VIGNOUD, J
    AHKONG, V
    SEMAINE DES HOPITAUX, 1988, 64 (01): : 9 - 13
12345